Yekaterina Chudnovsky
Board Member
Immix Biopharma, Inc. (IMMX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yekaterina Chudnovsky
Yekaterina Chudnovsky is recorded as Board Member at Immix Biopharma, Inc. (IMMX). Immix Biopharma, Inc. reported in an 8-K filed June 14, 2024 that Yekaterina Chudnovsky was appointed director, effective June 11, 2024. Immix Biopharma, Inc. reported in an 8-K filed August 22, 2023 that Yekaterina Chudnovsky was appointed Board of Directors. Immix Biopharma, Inc. reported in an 8-K filed August 22, 2023 that Yekaterina Chudnovsky was appointed member of the Board, effective August 22, 2023.
“The individuals listed below were elected at the Meeting to serve as directors of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified:”
“Upon the closing of the offering, the Board of Directors of the Company shall appoint Yekaterina Chudnovsky to the Board of Directors to serve until the 2024 annual meeting of stockholders of the Company and until her successor has been duly elected and qualified, or until her earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immix Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Ilya Rachman CEO, Board Member
- Gabriel Morris CFO, Board Member
- Carey Ng Board Member
- Helen C. Adams Board Member
- Jane Buchan Board Member
- Jason Hsu Board Member
- Magda Marquet Board Member
- Nancy Chang Board Member
- Nancy Chang, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.